These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25199240)

  • 41. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The dilemma of DCIS.
    Morrow M; O'Sullivan MJ
    Breast; 2007 Dec; 16 Suppl 2():S59-62. PubMed ID: 17714949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An argument against routine use of radiotherapy for ductal carcinoma in situ.
    Silverstein MJ
    Oncology (Williston Park); 2003 Nov; 17(11):1511-33; discussion 1533-4, 1539, 1542 passim. PubMed ID: 14682107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast-conserving therapy of ductal carcinoma in situ: frequency of local recurrence after wide excision with and without additional radiotherapy, a retrospective study of 42 cases.
    Vrouenraets BC; Peterse JL; van Dongen JA
    Neth J Surg; 1991 Jun; 43(3):51-5. PubMed ID: 1656327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of radiation after breast conserving surgery (BCS) for DCIS and early invasive breast cancer at Charleston Area Medical Center (CAMC). A study of compliance with National Comprehensive Cancer Network (NCCN) guidelines.
    Dean CT; Jubelirer SJ; Plants BA; Welch CA
    W V Med J; 2009 Oct; 105 Spec No():34-8; quiz 39. PubMed ID: 19999263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.
    Schouten van der Velden AP; Peeters PH; Koot VC; Hennipman A
    Ann Surg Oncol; 2006 Jul; 13(7):990-8. PubMed ID: 16788762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can some DCIS patients avoid adjuvant therapy? Still unknown.
    Schmidt C
    J Natl Cancer Inst; 2011 Apr; 103(7):530-1. PubMed ID: 21436062
    [No Abstract]   [Full Text] [Related]  

  • 48. Surgical margins in breast conservation therapy: how much should we excise?
    Law TT; Kwong A
    South Med J; 2009 Dec; 102(12):1234-7. PubMed ID: 20016431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biology and treatment of ductal carcinoma in situ.
    Irvine T; Fentiman IS
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):135-45. PubMed ID: 17288525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Controversies in breast conservation treatment for breast cancer].
    Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.
    Han K; Nofech-Mozes S; Narod S; Hanna W; Vesprini D; Saskin R; Taylor C; Kong I; Paszat L; Rakovitch E
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):183-9. PubMed ID: 21958729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrence after breast ablation for ductal carcinoma in situ.
    de Jong E; Peterse JL; van Dongen JA
    Eur J Surg Oncol; 1992 Feb; 18(1):64-6. PubMed ID: 1310646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of intraductal carcinomas. 91 cases treated at Oscar-Lambret Center].
    Patry-Lubeth MF; Giard S; Laurent JC
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(8):783-7. PubMed ID: 8636609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benefits of irradiation for DCIS: a Pyrrhic victory.
    Silverstein MJ; Lagios MD
    Lancet; 2000 Feb; 355(9203):510-1. PubMed ID: 10682994
    [No Abstract]   [Full Text] [Related]  

  • 57. Tamoxifen for intraductal cancer.
    Chan KC; Bundred NJ
    Lancet; 1999 Oct; 354(9185):1211-2. PubMed ID: 10513742
    [No Abstract]   [Full Text] [Related]  

  • 58. Adjuvant radiotherapy for DCIS.
    Joseph DJ; Spry N; Bydder S
    Lancet; 2000 Jun; 355(9220):2072; author reply 2072-3. PubMed ID: 10885376
    [No Abstract]   [Full Text] [Related]  

  • 59. Counterpoint: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice? RT Should Not Be Standard Practice After Surgery for DCIS.
    Wood WC
    Oncology (Williston Park); 2017 Aug; 31(8):637, 640-1. PubMed ID: 28831777
    [No Abstract]   [Full Text] [Related]  

  • 60. Adjuvant radiotherapy for DCIS.
    Millar J; Rodger A
    Lancet; 2000 Jun; 355(9220):2072; author reply 2072-3. PubMed ID: 10885375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.